Tilray Brands, Inc. ( TLRY) - Key Metrics
TLRY Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q4 | $2.52 | -$0.44 | -$0.34 | -$0.43 |
| 2026Q3 | $2.50 | -$0.32 | -$0.20 | -$0.23 |
| 2026Q2 | $2.75 | -$0.57 | -$0.11 | -$0.23 |
| 2026Q1 | $2.71 | $0 | -$0.02 | -$0.14 |
| 2025Q4 | $3.15 | -$17.86 | -$0.20 | -$0.30 |
TLRY Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q4 | 0% | -3.19 |
| 2026Q3 | 0% | -5.96 |
| 2026Q2 | 0% | -3.43 |
| 2026Q1 | 0% | -862.50 |
| 2025Q4 | 0% | -0.06 |
TLRY
Price: $3.94
52 week price:
Earnings Per Share: -1.09 USD
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: Canada
Volume: 12.7 million
Market Capitalization: 503.2 million